Page 10 - Roche India News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antibody cocktail launched in India | India News

NEW DELHI: Roche India and Cipla said that the first batch of antibody cocktail (Casirivimab and Imdevimab) is now available in India, while a second batch will be made available by mid-June. The antibody cocktail is for restricted use in emergency situation for the treatment of mild to moderate Covid, in patients who are at high risk of developing a severe disease, says a company statement. FacebookTwitterLinkedinEMail

Roche indiaரோச் இந்தியா

الهند تستعين بـ«دواء ترامب» لعلاج كورونا

الهند تستعين بـ«دواء ترامب» لعلاج كورونا
elwatannews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elwatannews.com Daily Mail and Mail on Sunday newspapers.

Swiss pharmaceuticalsRoche indiaசுவிஸ் மருந்துகள்ரோச் இந்தியா

Roche s COVID-19 antibody cocktail launched in India : Bulletin: Business Today

Roche s COVID-19 antibody cocktail launched in India : Bulletin: Business Today
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaSouth koreanElon muskMichael saylorRahul gandhiKia motorsCentral drugs standards control organisationKia indiaRoche indiaEmergency use authorisationBitcoin miningNorth americaஒன்றுபட்டது மாநிலங்களில்தெற்கு கொரியாதெற்கு கொரியன்

Coronavirus Latest News Live Updates: Pfizer, Moderna refused to sell COVID-19 vaccines directly to Delhi govt, says AAP

Coronavirus Latest News Live Updates: RDIF, Panacea Biotec launch production of Sputnik V vaccine in India Firstpost 35 minutes ago FP Staff © Provided by Firstpost Coronavirus Latest News Live Updates: RDIF, Panacea Biotec launch production of Sputnik V vaccine in India 15:43 (IST) RDIF and Panacea Biotec launch production of Sputnik V in India, say reports Russia’s sovereign wealth fund RDIF says Panacea Biotec has begun production of Sputnik vaccine in India, reports India Today, Panacea Biotec will produce 100 million doses of SputnikV per year. The first batch of Sputnik V produced at Panacea Biotec’s facilities will be shipped to the Gamaleya Research Institute of Epidemiology and Microbiology in Russia for quality control and full scale production is slated to start in the summer, reports the

Jammu and kashmirUttar pradeshUnited kingdomMadhya pradeshAndaman and nicobar islandsIndia generalTamil naduUnion territory of puducherryRamesh pokhriyal nishank drrpnishankSmriti iraniBarabanki sisaurhaAmarinder singhGautam gambhirCn ashwath narayanManish sisodiaRajesh rajora

Coronavirus Latest News Live Updates: Supreme Court seeks Centre s reply on compensation to COVID-19 victims kin

Coronavirus Latest News Live Updates: Over one crore Indians in 18-44 age group vaccinated so far, says health ministry Firstpost 37 minutes ago FP Staff © Provided by Firstpost Coronavirus Latest News Live Updates: Over one crore Indians in 18-44 age group vaccinated so far, says health ministry 15:29 (IST) Coronavirus Latest Updates Nothing wrong in Delhi govt order putting all doctors in one category for treating COVID patients,says HC The Delhi High Court Monday said there was nothing wrong in the decision of the Delhi Government directing all doctors and medical staff to function in a single category, irrespective of the differences in their seniority and specialisation, in treatment of COVID patients, saying there should not be any ego issue . Justice Rekha Palli said that prima facie there was nothing wrong with the 16 May notification which appeared to be dealing only with COVID management duties of doctors and they should not come to cou

Jammu and kashmirUttar pradeshUnited kingdomMadhya pradeshAndaman and nicobar islandsTamil naduUnion territory of puducherryRamesh pokhriyal nishank drrpnishankSmriti iraniBarabanki sisaurhaAmarinder singhGautam gambhirCn ashwath narayanRajesh rajoraHarsh vardhanMatt hancock